Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to compare the relative efficacy and safety of the test formulation of ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension (Par) to the already-marketed formulation CIPRODEX® (ciprofloxacin 0.3%/dexamethasone 0.1%) sterile otic suspension (Alcon) in the treatment of acute bacterial otitis media in children with patent tympanostomy tubes.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01994642
Study type Interventional
Source Par Pharmaceutical, Inc.
Contact
Status Terminated
Phase Phase 3
Start date November 2013
Completion date March 2015